Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X‐Linked Hypophosphatemia: Results From the Phase 3, Single‐Arm International Trial-Reference-Cited by-同舟云学术

Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X‐Linked Hypophosphatemia: Results From the Phase 3, Single‐Arm International Trial

Published:2022-08-10 Issue:9 Volume:37 Page:1665-1678
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Fratzl‐Zelman Nadja¹²^ORCID,Hartmann Markus A.¹²^ORCID,Gamsjaeger Sonja¹^ORCID,Rokidi Stamatia¹,Paschalis Eleftherios P.¹²,Blouin Stéphane¹²^ORCID,Zwerina Jochen¹²

Affiliation:

1. Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling 1st Med Department Hanusch Hospital Vienna Austria

2. Vienna Bone and Growth Center Vienna Austria

Funder

Ultragenyx Pharmaceutical

Allgemeine Unfallversicherungsanstalt

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4641

Reference80 articles.

1. A clinician's guide to X-linked hypophosphatemia